Aging · 2021 · 18 citations · 75 references
MedicineMolecular BiologyOncologyCancer ImmunologyMolecular OncologyNeoplasiaCancer BiomarkersCancer GenomicsCancer Molecular PathologyImmuno-oncology BiomarkersMolecular Classification Of TumorsMolecular Tumor ProfilingDifferential Co-expression AnalysisImmunotherapy Response BiomarkersLung AdenocarcinomaN6-methyladenosine RegulationPrognostic Biomarker DiscoveryPrognostic Gene SignaturesResponse To ImmunotherapyTumor Mutational Burden
T cells in the tumor tissues and improved response to immune checkpoint blockade therapy. These findings show that this five-m6A regulatory gene signature is a prognostic biomarker in LADC and that immune checkpoint blockade is a potential therapeutic option for high-risk LADC patients.
75
Rebecca L. Siegel, Kimberly D. Miller, Ahmedin Jemal · CA A Cancer Journal for Clinicians · 2017 · 15K citations · Full text
Robust enumeration of cell subsets from tissue expression profiles
Aaron M. Newman, Chih Long Liu, Michael R. Green et al. · Nature Methods · 2015 · 14.1K citations · Full text
Inferring tumour purity and stromal and immune cell admixture from expression data
Kosuke Yoshihara, Maria Shahmoradgoli, Emmanuel Martínez et al. · Nature Communications · 2013 · 10.7K citations · Full text
Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer
Edward B. Garon, Naiyer A. Rizvi, Rina Hui et al. · New England Journal of Medicine · 2015 · 6.2K citations · Full text
Medicine, Oncology, Pharmacology +17
Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response
Peng Jiang, Shengqing Gu, Deng Pan et al. · Nature Medicine · 2018 · 5.6K citations · Full text
Life Sciences, Immunology, Oncology +14